Canton Strategic Holdings, Inc. (CNTN)
1.68
-0.02
(-0.88%)
USD |
NASDAQ |
Oct 19, 15:47
Canton Strategic Holdings Enterprise Value : 93.74M for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 93.74M |
| October 15, 2026 | 107.26M |
| October 14, 2026 | 104.55M |
| October 13, 2026 | 118.85M |
| October 12, 2026 | 125.80M |
| October 09, 2026 | 125.80M |
| October 08, 2026 | 123.49M |
| October 07, 2026 | 137.40M |
| October 06, 2026 | 143.58M |
| October 05, 2026 | 142.80M |
| October 02, 2026 | 136.62M |
| October 01, 2026 | 131.60M |
| September 30, 2026 | 146.28M |
| September 29, 2026 | 146.67M |
| September 28, 2026 | 170.62M |
| September 25, 2026 | 161.35M |
| September 24, 2026 | 141.26M |
| September 23, 2026 | 135.85M |
| September 22, 2026 | 152.08M |
| September 21, 2026 | 151.30M |
| September 18, 2026 | 140.49M |
| September 17, 2026 | 125.03M |
| September 16, 2026 | 120.40M |
| September 15, 2026 | 120.78M |
| September 14, 2026 | 125.03M |
| Date | Value |
|---|---|
| September 11, 2026 | 125.80M |
| September 10, 2026 | 128.90M |
| September 09, 2026 | 133.53M |
| September 08, 2026 | 135.08M |
| September 04, 2026 | 138.94M |
| September 03, 2026 | 136.62M |
| September 02, 2026 | 123.49M |
| September 01, 2026 | 138.94M |
| August 31, 2026 | 138.94M |
| August 28, 2026 | 134.30M |
| August 27, 2026 | 144.35M |
| August 26, 2026 | 135.08M |
| August 25, 2026 | 141.26M |
| August 24, 2026 | 128.12M |
| August 21, 2026 | 131.99M |
| August 20, 2026 | 133.53M |
| August 19, 2026 | 124.26M |
| August 18, 2026 | 118.08M |
| August 17, 2026 | 119.24M |
| August 14, 2026 | 118.85M |
| August 13, 2026 | 114.99M |
| August 12, 2026 | 114.99M |
| August 11, 2026 | 109.58M |
| August 10, 2026 | 107.26M |
| August 07, 2026 | 107.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 7.664B |
| Oncolytics Biotech, Inc. | 58.41M |
| Sangamo Therapeutics, Inc. | 37.40M |
| Sarepta Therapeutics, Inc. | 2.064B |
| Anixa Biosciences, Inc. | 77.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.95M |
| Revenue (Quarterly) | 1.496M |
| Total Expenses (Quarterly) | 19.45M |
| EPS Diluted (Quarterly) | -0.0888 |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -86.08% |
| Normalized Earnings Yield | -53.80 |